CERENOME, INC. - 8-K Filing

Cerenome reports Q3 2026 net loss of $8.7 million and $0.7 million in diagnostic revenue. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PSTV

Read the full article at SEC EDGAR

More Regulatory news